Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · IEX Real-Time Price · USD
0.621
+0.009 (1.52%)
Jun 21, 2024, 1:36 PM EDT - Market open

Sensei Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018
Cash & Equivalents
13.0117.87.1616.60.7
Upgrade
Short-Term Investments
52.7589.32140.4600
Upgrade
Cash & Cash Equivalents
65.76107.12147.6216.60.7
Upgrade
Cash Growth
-38.61%-27.44%789.50%2277.65%-36.55%
Upgrade
Other Current Assets
1.491.470.923.48-0.2
Upgrade
Total Current Assets
67.25108.59148.5420.080.5
Upgrade
Property, Plant & Equipment
7.049.724.641.270.27
Upgrade
Other Long-Term Assets
0.090.060.040.090.45
Upgrade
Total Long-Term Assets
7.129.794.681.350.72
Upgrade
Total Assets
74.37118.38153.2321.431.22
Upgrade
Accounts Payable
1.694.472.463.883.55
Upgrade
Current Debt
2.442.130.680.0316.06
Upgrade
Other Current Liabilities
1.512.461.750.922.11
Upgrade
Total Current Liabilities
5.649.074.894.8321.71
Upgrade
Long-Term Debt
3.775.91.670.650
Upgrade
Other Long-Term Liabilities
0.0700.150.050.62
Upgrade
Total Long-Term Liabilities
3.845.91.820.710.62
Upgrade
Total Liabilities
9.4814.976.715.5422.33
Upgrade
Total Debt
6.218.032.350.6916.06
Upgrade
Debt Growth
-22.72%241.25%243.65%-95.73%238.28%
Upgrade
Retained Earnings
-231.9-197.79-149.21-112.41-92.31
Upgrade
Comprehensive Income
-0.21-1-0.3300
Upgrade
Shareholders' Equity
64.9103.41146.51-56.44-68.66
Upgrade
Net Cash / Debt
59.5599.08145.2715.91-15.36
Upgrade
Net Cash / Debt Growth
-39.90%-31.79%813.00%--
Upgrade
Net Cash Per Share
2.133.235.249.87-41.80
Upgrade
Working Capital
61.6199.52143.6515.25-21.21
Upgrade
Book Value Per Share
2.323.375.29-35.01-186.91
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).